{
  "docId": "019dd923-622c-750b-8b97-5cb48bf2a635",
  "docSlug": "b8afd3741673",
  "documentTitle": "Chinook Therapeutics Inc (KDNY)",
  "authorId": "51_Muddy_Waters",
  "authorName": "Carson C. Block",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-05-16 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 13,
  "pageCount": 36,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a table to highlight discrepancies in mortality reporting between the 'Enrichment' group and the 'Double-Blind' groups.",
  "elementsJson": [
    "paragraph",
    "data_table",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b97-5cb48bf2a635/13",
  "deckHref": "/decks/019dd923-622c-750b-8b97-5cb48bf2a635",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b97-5cb48bf2a635.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b97-5cb48bf2a635#slide-13",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The death rate, per-person per-unit-of-time, in the enrichment period was elevated in comparison to placebo for the double-blind period.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-25b7-709e-b8d0-42e36f321e61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "All-Cause Mortality: 4.59%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-25b7-709e-b8d0-48e668b747d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.125,
        "y": 0.625
      },
      "kind": "paragraph",
      "text": "The death rate, per-person per-unit-of-time, in the enrichment period was elevated in comparison to placebo for the double-blind period. We must be cautious in drawing conclusions... but the study authors’ apparent failure to discuss these deaths",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0618fbcd-7e21-4f02-8253-05b265b3473c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.125,
        "y": 0.095
      },
      "kind": "paragraph",
      "text": "related to any safety concerns. But both the presentation of the data and the results themselves suggest that this is untrue; the much likelier explanation for SONAR’s unexpected and abrupt closure is a combination of safety concerns and a desire to cut research short",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9149218f-fa02-4944-a0f9-f66fb0ba0937",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Chinook, however, says that AbbVie's research showed an \"acceptable safety profile\" for atrasentan, with \"no severe adverse events related to study drug to date\".",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-25b7-709e-b8d0-45ca48e6a953",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.125,
        "y": 0.78
      },
      "kind": "source-note",
      "text": "Footnotes 76-82 detailing sources for the clinical trial data and statements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48cc75e5-45db-4e47-8c45-e7c04d9891c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.125,
        "y": 0.425
      },
      "kind": "table",
      "text": "Table comparing mortality rates across Enrichment Atrasentan, Double-Blind Atrasentan, and Double-Blind Placebo groups.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "118141d2-e4a1-4d87-b4aa-e1c8d117379f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "e6df4566-126b-479d-8815-89e9a7d09ab1",
      "evidence": "The slide explicitly argues that facts were finessed and data was concealed to distort trial results.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 6,
      "beatId": "7c7d9806-d739-4215-b62f-052b350305ec",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle",
      "beatSlug": "overcoming-monster-the-struggle",
      "evidence": "The report presents the 'struggle' of analyzing the data and identifying issues",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 6,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "437b3fa7-133f-4a21-908b-7e42915fbdb3",
      "evidence": "The report presents a series of data analyses that reveal inconsistencies",
      "position": 0,
      "objective": "To identify patterns in the data that suggest issues with the trial results",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}